Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery.
Stefania CamastraAlessandra VitaliMarco AnselminoFrancesco RubinoRosario BelliniRossana BertaIlenia SeveriSimona BaldiBrenno AstiarragaGiorgio BarbatelliSaverio CintiEle FerranniniPublished in: Scientific reports (2017)
Obesity is characterized by insulin-resistance (IR), enhanced lipolysis, and ectopic, inflamed fat. We related the histology of subcutaneous (SAT), visceral fat (VAT), and skeletal muscle to the metabolic abnormalities, and tested their mutual changes after bariatric surgery in type 2 diabetic (T2D) and weight-matched non-diabetic (ND) patients. We measured IR (insulin clamp), lipolysis (2H5-glycerol infusion), ß-cell glucose-sensitivity (ß-GS, mathematical modeling), and VAT, SAT, and rectus abdominis histology (light and electron microscopy). Presurgery, SAT and VAT showed signs of fibrosis/necrosis, small mitochondria, free interstitial lipids, thickened capillary basement membrane. Compared to ND, T2D had impaired ß-GS, intracapillary neutrophils and higher intramyocellular fat, adipocyte area in VAT, crown-like structures (CLS) in VAT and SAT with rare structures (cyst-like) ~10-fold larger than CLS. Fat expansion was associated with enhanced lipolysis and IR. VAT histology and intramyocellular fat were related to impaired ß-GS. Postsurgery, IR and lipolysis improved in all, ß-GS improved in T2D. Muscle fat infiltration was reduced, adipocytes were smaller and richer in mitochondria, and CLS density in SAT was reduced. In conclusion, IR improves proportionally to weight loss but remains subnormal, whilst SAT and muscle changes disappear. In T2D postsurgery, some VAT pathology persists and beta-cell dysfunction improves but is not normalized.
Keyphrases
- adipose tissue
- insulin resistance
- bariatric surgery
- weight loss
- skeletal muscle
- high fat diet
- obese patients
- type diabetes
- high fat diet induced
- polycystic ovary syndrome
- end stage renal disease
- gastric bypass
- roux en y gastric bypass
- glycemic control
- single cell
- chronic kidney disease
- metabolic syndrome
- fatty acid
- stem cells
- cell death
- cell therapy
- low dose
- ejection fraction
- blood glucose
- blood pressure
- newly diagnosed
- ultrasound guided
- wound healing
- physical activity
- prognostic factors
- reactive oxygen species
- endoplasmic reticulum